Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors.
about
Medical treatment for gastro-entero-pancreatic neuroendocrine tumoursPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsManagement Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature.Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study.Overexpression of SSAT by DENSPM treatment induces cell detachment and apoptosis in glioblastoma.Systemic therapy for advanced pancreatic neuroendocrine tumorsTherapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitationsLong-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors.PI3K/AKT/mTOR pathway in pulmonary carcinoid tumours.Treatment of neuroendocrine tumor liver metastases.Everolimus in combination with octreotide long-acting repeatable in a first-line setting for patients with neuroendocrine tumors: an ITMO group study
P2860
Q26751659-126718C9-8816-403D-92E5-A552EDA8D1A9Q26862544-B79D08C9-C485-4422-A61F-A87EAB820B41Q33737587-88F65CF1-6C1D-4F58-94BC-A399BCB38A96Q36565634-6E317E65-B5FE-448B-8BBC-7E9DCC5FBD61Q36642473-9F2AEB62-595E-43C6-8EDC-593FEA9E980FQ38079854-A0BCFE82-5ABB-4781-877E-B3C28995521DQ38208069-2E134F5A-1CE0-4FA1-B49E-BDC60EBA5C9DQ38786234-0C9ABA98-60B9-4554-85D3-CF1EF44F55EBQ41143784-73D90D77-767F-4E28-A63E-671D8090D7C9Q42287138-2D6870D4-B12E-47AF-AFEE-5715530059E0Q57109641-6AC24C6D-7A5D-4639-9CA9-38B970A1CD1F
P2860
Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Innovations therapy: mammalian ...... ment of neuroendocrine tumors.
@en
Innovations therapy: mammalian target of rapamycin
@nl
type
label
Innovations therapy: mammalian ...... ment of neuroendocrine tumors.
@en
Innovations therapy: mammalian target of rapamycin
@nl
prefLabel
Innovations therapy: mammalian ...... ment of neuroendocrine tumors.
@en
Innovations therapy: mammalian target of rapamycin
@nl
P2093
P2860
P1476
Innovations therapy: mammalian ...... ment of neuroendocrine tumors.
@en
P2093
Albert Abad
Irene Halperín
James C Yao
Jaume Capdevila
Ramón Salazar
P2860
P2888
P356
10.1007/S10555-011-9290-3
P478
30 Suppl 1
P577
2011-03-01T00:00:00Z